Sonnet BioTherapeutics (SONN) Competitors $4.73 +0.81 (+20.66%) Closing price 07/7/2025 04:00 PM EasternExtended Trading$5.24 +0.52 (+10.89%) As of 07/7/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SONN vs. ZIVO, QNTM, CRVO, AADI, BLUE, OSTX, VTVT, DTIL, HOWL, and ALGSShould you be buying Sonnet BioTherapeutics stock or one of its competitors? The main competitors of Sonnet BioTherapeutics include ZIVO Bioscience (ZIVO), Quantum Biopharma (QNTM), CervoMed (CRVO), Aadi Bioscience (AADI), bluebird bio (BLUE), OS Therapies (OSTX), vTv Therapeutics (VTVT), Precision BioSciences (DTIL), Werewolf Therapeutics (HOWL), and Aligos Therapeutics (ALGS). These companies are all part of the "pharmaceutical products" industry. Sonnet BioTherapeutics vs. Its Competitors ZIVO Bioscience Quantum Biopharma CervoMed Aadi Bioscience bluebird bio OS Therapies vTv Therapeutics Precision BioSciences Werewolf Therapeutics Aligos Therapeutics ZIVO Bioscience (NASDAQ:ZIVO) and Sonnet BioTherapeutics (NASDAQ:SONN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings and media sentiment. Which has more volatility & risk, ZIVO or SONN? ZIVO Bioscience has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500. Comparatively, Sonnet BioTherapeutics has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Which has better valuation & earnings, ZIVO or SONN? Sonnet BioTherapeutics has higher revenue and earnings than ZIVO Bioscience. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZIVO Bioscience$15.85K3,130.66-$7.78M-$4.93-2.64Sonnet BioTherapeutics$20K749.71-$7.44MN/AN/A Is ZIVO or SONN more profitable? ZIVO Bioscience's return on equity of 0.00% beat Sonnet BioTherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets ZIVO BioscienceN/A N/A -2,240.92% Sonnet BioTherapeutics N/A -777.92%-271.32% Do insiders and institutionals have more ownership in ZIVO or SONN? 12.8% of ZIVO Bioscience shares are held by institutional investors. Comparatively, 9.5% of Sonnet BioTherapeutics shares are held by institutional investors. 48.9% of ZIVO Bioscience shares are held by insiders. Comparatively, 2.0% of Sonnet BioTherapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts rate ZIVO or SONN? Sonnet BioTherapeutics has a consensus price target of $20.00, suggesting a potential upside of 322.83%. Given Sonnet BioTherapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Sonnet BioTherapeutics is more favorable than ZIVO Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ZIVO Bioscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sonnet BioTherapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor ZIVO or SONN? In the previous week, Sonnet BioTherapeutics had 3 more articles in the media than ZIVO Bioscience. MarketBeat recorded 3 mentions for Sonnet BioTherapeutics and 0 mentions for ZIVO Bioscience. ZIVO Bioscience's average media sentiment score of 0.00 equaled Sonnet BioTherapeutics'average media sentiment score. Company Overall Sentiment ZIVO Bioscience Neutral Sonnet BioTherapeutics Neutral SummarySonnet BioTherapeutics beats ZIVO Bioscience on 8 of the 12 factors compared between the two stocks. Get Sonnet BioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SONN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SONN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SONN vs. The Competition Export to ExcelMetricSonnet BioTherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.41M$2.91B$5.52B$9.02BDividend YieldN/A2.44%5.24%4.08%P/E RatioN/A20.4427.2620.04Price / Sales749.71190.07381.2593.27Price / CashN/A41.7026.2128.59Price / Book-6.667.397.945.55Net Income-$7.44M-$55.04M$3.17B$248.49M7 Day Performance290.91%2.51%1.80%4.87%1 Month Performance278.40%-0.21%1.28%6.63%1 Year Performance-34.31%3.41%33.57%20.38% Sonnet BioTherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SONNSonnet BioTherapeutics2.6334 of 5 stars$4.73+20.7%$20.00+322.8%-35.0%$12.41M$20K0.0010News CoverageGap UpHigh Trading VolumeZIVOZIVO BioscienceN/A$13.00+8.4%N/A+52.9%$49.62M$15.85K-2.6610Gap UpQNTMQuantum BiopharmaN/A$16.56-2.9%N/AN/A$49.60MN/A-1.04N/ACRVOCervoMed3.2625 of 5 stars$5.87+3.9%$27.63+370.6%-62.1%$49.17M$9.74M-2.694Positive NewsAADIAadi Bioscience0.6439 of 5 stars$1.99+5.9%$1.67-16.2%+49.6%$49.15M$25.07M-0.8740BLUEbluebird bio2.1034 of 5 stars$4.97flat$44.60+797.4%N/A$48.67M$103.95M-0.13520OSTXOS Therapies2.636 of 5 stars$1.73-5.5%$18.00+940.5%N/A$48.61MN/A-2.01N/AGap UpVTVTvTv Therapeutics1.9501 of 5 stars$15.10+0.2%$35.50+135.2%-14.1%$48.14M$1.02M-5.019DTILPrecision BioSciences4.4876 of 5 stars$4.31-0.7%$47.00+990.5%-53.2%$48.12M$68.70M-2.14200HOWLWerewolf Therapeutics3.0498 of 5 stars$1.05-1.9%$8.33+693.7%-49.5%$48.01M$1.88M-0.6340ALGSAligos Therapeutics3.0838 of 5 stars$7.50-4.3%$70.00+833.3%-25.8%$47.94M$3.94M-0.4390 Related Companies and Tools Related Companies ZIVO Bioscience Competitors Quantum Biopharma Competitors CervoMed Competitors Aadi Bioscience Competitors bluebird bio Competitors OS Therapies Competitors vTv Therapeutics Competitors Precision BioSciences Competitors Werewolf Therapeutics Competitors Aligos Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SONN) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonnet BioTherapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonnet BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
